Trade Report: Today, Fisher Asset Management LLC Buys 8,060 Shares of The Cooper Cos. (COO)

Today, Fisher Asset Management LLC Buys 8,060 Shares of The Cooper Cos. (COO)

Fisher Asset Management LLC increased its stake in The Cooper Cos. (NYSE:COO) by 7.5% during the third quarter, Holdings Channel reports. The firm owned 114,974 shares of the medical device company’s stock after buying an additional 8,060 shares during the period. Fisher Asset Management LLC’s holdings in The Cooper Cos. were worth $20,610,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently bought and sold shares of COO. Legacy Private Trust Co. raised its stake in The Cooper Cos. by 2.1% in the second quarter. Legacy Private Trust Co. now owns 3,365 shares of the medical device company’s stock valued at $577,000 after buying an additional 70 shares during the period. Beacon Financial Group raised its stake in The Cooper Cos. by 67.4% in the second quarter. Beacon Financial Group now owns 4,489 shares of the medical device company’s stock valued at $762,000 after buying an additional 1,807 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in The Cooper Cos. by 2.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 17,615 shares of the medical device company’s stock valued at $3,022,000 after buying an additional 440 shares during the period. TT International bought a new stake in The Cooper Cos. during the second quarter valued at approximately $2,072,000. Finally, British Columbia Investment Management Corp raised its stake in The Cooper Cos. by 11.9% in the second quarter. British Columbia Investment Management Corp now owns 24,085 shares of the medical device company’s stock valued at $4,132,000 after buying an additional 2,554 shares during the period. 94.19% of the stock is currently owned by hedge funds and other institutional investors.

Shares of The Cooper Cos. (NYSE:COO) traded up 1.20% during trading on Friday, reaching $170.70. The company had a trading volume of 376,622 shares. The Cooper Cos. has a 12 month low of $119.28 and a 12 month high of $190.99. The firm has a market capitalization of $8.32 billion, a P/E ratio of 33.42 and a beta of 0.62. The firm’s 50 day moving average price is $176.62 and its 200 day moving average price is $175.54.

The Cooper Cos. (NYSE:COO) last posted its quarterly earnings data on Thursday, September 1st. The medical device company reported $2.30 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.29 by $0.01. The firm earned $514.70 million during the quarter. The Cooper Cos. had a return on equity of 14.89% and a net margin of 13.14%. The firm’s revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.97 earnings per share. Equities analysts predict that The Cooper Cos. will post $8.43 EPS for the current year.

Several analysts recently commented on the company. Stifel Nicolaus reaffirmed a “buy” rating and set a $215.00 target price on shares of The Cooper Cos. in a report on Friday, September 9th. Jefferies Group raised their target price on The Cooper Cos. from $190.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, August 24th. BMO Capital Markets raised their target price on The Cooper Cos. from $199.00 to $206.00 and gave the stock an “outperform” rating in a report on Friday, September 2nd. Wells Fargo & Co. reaffirmed a “hold” rating on shares of The Cooper Cos. in a report on Sunday, September 11th. Finally, Zacks Investment Research lowered The Cooper Cos. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $187.80.

In other The Cooper Cos. news, EVP Albert G. White III sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $185.72, for a total transaction of $3,714,400.00. Following the transaction, the executive vice president now owns 41,639 shares in the company, valued at approximately $7,733,195.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William A. Kozy bought 270 shares of the company’s stock in a transaction on Tuesday, September 6th. The shares were acquired at an average price of $186.69 per share, for a total transaction of $50,406.30. Following the transaction, the director now directly owns 770 shares in the company, valued at approximately $143,751.30. The disclosure for this purchase can be found here. Company insiders own 2.20% of the company’s stock.

About The Cooper Cos.

The Cooper Companies, Inc (Cooper) is a medical device company. The Company operates through two business units: CooperVision, Inc (CooperVision) and CooperSurgical, Inc (CooperSurgical). CooperVision develops, manufactures and markets a range of soft contact lenses for the vision correction market. CooperVision offers Biofinity monthly spherical, toric and multifocal lenses under the Avaira brand.

Related posts

Leave a Comment